Use fundamental data analysis to confirm all available drivers of ResMed Inc to find out if markets are presently mispricing the firm. We found thirty-six available financial ratios for ResMed Inc which can be compared to its competitors. To make sure the equity is not overpriced, please check all ResMed Inc fundamentals including its Book Value Per Share, Retained Earnings and the relationship between Cash per Share and Number of Employees . Given that ResMed Inc has Price to Earning of 36.09 times, we recommend you check out ResMed Inc recent market performance to make sure the company can sustain itself down the road.Use ResMed to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of ResMed to be traded at $86.04 in 30 days
ResMed Inc Valuation Over Time
ResMed Company SummaryResMed competes with DexCom, Boston Scientific, Cooper Companies, Quest Diagnostics, and DENTSPLY INTL. Its portfolio of solutions include devices such as air flow generators ventilators and oxygen concentrators diagnostic products mask systems headgear and other accessories dental devices portable oxygen concentrators and cloudbased software informatics solutions. ResMed Inc also produces continuous positive airway pressure variable positive airway pressure and AutoSet systems for the titration and treatment of sleep disordered breathing . In addition it offers data communications and control products such as EasyCare ResLink ResControl ResControl II TxControl ResScan and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc markets its solutions to sleep clinics home healthcare dealers patients hospitals physicians and thirdparty payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego California.
ResMed Current Valuation vs Book Value Per Share
ResMed Inc is rated fifth in current valuation category among related companies. It is rated fifth in book value per share category among related companies . The ratio of Current Valuation to Book Value Per Share for ResMed Inc is about 888,272,033